Cargando…
Does a ketogenic diet as an adjuvant therapy for drug treatment enhance chemotherapy sensitivity and reduce target lesions in patients with locally recurrent or metastatic Her-2-negative breast cancer? Study protocol for a randomized controlled trial
BACKGROUND: Recent studies have indicated that a ketogenic diet can be used as an adjuvant therapy to enhance sensitivity to chemotherapy and radiotherapy in cancer patients. However, there are no sufficient data and no consistent international treatment guidelines supporting a ketogenic diet as an...
Autores principales: | Wang, Yan, Jing, Ming-Xi, Jiang, Lei, Jia, Yu-Feng, Ying, E., Cao, Hui, Guo, Xiang-Yu, Sun, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275564/ https://www.ncbi.nlm.nih.gov/pubmed/32503654 http://dx.doi.org/10.1186/s13063-020-04429-5 |
Ejemplares similares
-
Ketogenic diets as an adjuvant therapy in glioblastoma (the KEATING trial): study protocol for a randomised pilot study
por: Martin-McGill, Kirsty J., et al.
Publicado: (2017) -
Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism
por: Allen, Bryan G., et al.
Publicado: (2014) -
De-escalation of adjuvant chemotherapy for HER2 negative breast cancer
por: Okines, Dr Alicia FC, et al.
Publicado: (2021) -
The Ketogenic Diet Is an Effective Adjuvant to Radiation Therapy for the Treatment of Malignant Glioma
por: Abdelwahab, Mohammed G., et al.
Publicado: (2012) -
Negative genic switch of HER-2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2-positive breast cancer
por: Chen, Hao-ran, et al.
Publicado: (2017)